SOBRE JAAKKO KAPRIO
Jaakko Kaprio, M.D., Ph.D. is a Research Director at the Institute for Molecular Medicine FIMM, University of Helsinki and was Professor of Genetic Epidemiology, University of Helsinki, Finland since 2001 until mandatory retirement in April 2020. He held a five-year research professorship fully funded by the Academy of Finland from 2013 to 2017. The Academy Professorship research theme was on genetics, epigenetics and epidemiology of smoking and nicotine dependence.  He was Director of FIMM from Oct 1, 2015 to January 31, 2018; FIMM is an EMBL-associated biomedical research institute focusing on personalized cancer therapies, large-scale genetics studies (such as FinnGen) and use of AI in digital pathology. Dr. Kaprio has worked in genetic epidemiology with a focus on risk factors of non-communicable disease, especially smoking and alcohol use and dependence. He has worked with the Finnish Twin Cohort studies since 1976, and with other population-based samples in Finland. He has engaged in extensive international collaborations, including multiple NIH and EU funded projects. He has served as President of the Society for Research on Nicotine and Tobacco European chapter, as President of the Behavior Genetics Association and as President of the International Society for Twin Studies. He has been active in cancer and tobacco-related NGOs in Finland. He has supervised over 50 PhD students, been awarded two honorary doctorates and many other prizes. He has published over 1300 papers, as listed in PubMed.